Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy

NCT05432232 is registered in ClinicalTrials.gov with HistoSonics, Inc. as lead sponsor.

NCT NCT05432232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05432232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Lead sponsor
HistoSonics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 23, 2023
Completion date
June 6, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, kidney neoplasms, renal cancer, tumor, tumor, benign, tumor, solid